Primer: Adagene Inc (ADAG US) - Aug 2026
Adagene is a clinical-stage biotechnology company focused on developing novel antibody-based cancer immunotherapies, distinguished by its...
100 Views
Meihua International Medical Technologies Pre-IPO: Risks Overshadow Cheap Valuation
Meihua plans to raise $50 million by offering 5 million shares. At midpoint, the company would command a market cap of $250 million. Shares are...
538 Views
Pre-IPO Adagene Inc (ADAG US) - Advanced Technology but Still Take Time for Commercialization
This article analyzed Adagene Inc. in terms of the DPL platform, the core products in the pipeline (ADG106, ADG126 and ADG116), the financial...
504 Views